Modern antiglaucoma agents and their secondary effects;Les medicaments antiglaucomateux modernes et leurs effets secondaires

Revue Medicale de la Suisse Romande

Volumn 118, Issue 11, 1998, Pages 937-940

  Mermoud, André ^a  

^a HÔPITAL OPHTALMIQUE JULES GONIN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRIMONIDINE; CLONIDINE; DORZOLAMIDE; LATANOPROST; MANNITOL; PILOCARPINE; UNOPROSTONE ISOPROPYL ESTER; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; CARBONATE DEHYDRATASE INHIBITOR; DRUG DERIVATIVE; PROSTAGLANDIN F2 ALPHA; QUINOXALINE DERIVATIVE; SULFONAMIDE; THIOPHENE DERIVATIVE;

DRUG EFFECT; DRUG EFFICACY; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; SHORT SURVEY; ARTICLE;

ADRENERGIC ALPHA-AGONISTS; CARBONIC ANHYDRASE INHIBITORS; DINOPROST; GLAUCOMA; HUMANS; QUINOXALINES; SULFONAMIDES; THIOPHENES;

EID: 0032200832     PISSN: 00353655     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (2)

1. Robin A.L., Novack G.D.: α2-agonists in therapy of glaucoma. In: Drance S.M., Van Buskirk E.M., Neufeld A.H., eds. Pharmacology of glaucoma. Baltimore, Williams and Wilkins, 103-104, 1992.
2. Gharagozloo N.Z., Brubaker R.F.: Effect of Apraclonidine in longterme timolol users. Ophthalmology, 98: 1075-1078, 1989.